Cookson MS - Search Results

1

Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study.

Cookson MS, Sogani PC, Russo P, Sheinfeld J, Herr H, Dalbagni G, Reuter VE, Begg CB, Fair WR. Cookson MS, et al. Br J Urol. 1997 Mar;79(3):432-8. doi: 10.1046/j.1464-410x.1997.00022.x. Br J Urol. 1997. PMID: 9117227 Clinical Trial.

2

Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy.

Cookson MS, Sarosdy MF. Cookson MS, et al. J Urol. 1992 Sep;148(3):797-801. doi: 10.1016/s0022-5347(17)36724-1. J Urol. 1992. PMID: 1512829 Review.

3

The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels.

Cookson MS, Floyd MK, Ball TP Jr, Miller EK, Sarosdy MF. Cookson MS, et al. J Urol. 1995 Sep;154(3):1070-3. J Urol. 1995. PMID: 7543601 Clinical Trial.

4

Upper tract tumors in patients with primary bladder cancer followed for 15 years.

Herr HW, Cookson MS, Soloway SM. Herr HW, et al. Among authors: cookson ms. J Urol. 1996 Oct;156(4):1286-7. J Urol. 1996. PMID: 8808855

5

Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications.

Cookson MS, Fleshner NE, Soloway SM, Fair WR. Cookson MS, et al. J Urol. 1997 Feb;157(2):559-62. J Urol. 1997. PMID: 8996356

6

Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue.

Cookson MS, Reuter VE, Linkov I, Fair WR. Cookson MS, et al. J Urol. 1997 Feb;157(2):673-6. J Urol. 1997. PMID: 8996396

7

Clinical significance of repeat sextant biopsies in prostate cancer patients.

Stroumbakis N, Cookson MS, Reuter VE, Fair WR. Stroumbakis N, et al. Among authors: cookson ms. Urology. 1997 Mar;49(3A Suppl):113-8. doi: 10.1016/s0090-4295(97)00178-7. Urology. 1997. PMID: 9123730 Clinical Trial.

8

The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.

Fair WR, Cookson MS, Stroumbakis N, Cohen D, Aprikian AG, Wang Y, Russo P, Soloway SM, Sogani P, Sheinfeld J, Herr H, Dalgabni G, Begg CB, Heston WD, Reuter VE. Fair WR, et al. Among authors: cookson ms. Urology. 1997 Mar;49(3A Suppl):46-55. doi: 10.1016/s0090-4295(97)00169-6. Urology. 1997. PMID: 9123736 Clinical Trial.

9

Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction.

Su SL, Heston WD, Perrotti M, Cookson MS, Stroumbakis N, Huyrk R, Edwards E, Brander B, Coke J, Soloway S, Lewis A, Fair WR. Su SL, et al. Among authors: cookson ms. Urology. 1997 Mar;49(3A Suppl):95-101. doi: 10.1016/s0090-4295(97)00175-1. Urology. 1997. PMID: 9123743 Review.

10

The treated natural history of high risk superficial bladder cancer: 15-year outcome.

Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. Cookson MS, et al. J Urol. 1997 Jul;158(1):62-7. doi: 10.1097/00005392-199707000-00017. J Urol. 1997. PMID: 9186324 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters